{"nct_id":"NCT00617253","title":"Combination of Recombinant Human IL-21 (rIL-21) and Sunitinib in Stage IV Renal Cell Carcinoma Patients","status":"COMPLETED","status_verified_date":"2017-02","start_date":"2007-07-12","start_date_type":"ACTUAL","primary_completion_date":"2008-06-30","primary_completion_date_type":"ACTUAL","completion_date":"2008-06-30","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVO"]}